CEO Yosuke Ozawa Presents at the 7th National Medical AI Contest Kickoff Event
On December 27, 2025, Epistra Inc. CEO Yosuke Ozawa presented at the online kickoff event of the 7th National Medical AI Contest.
The contest is a data analysis competition open to students, healthcare professionals, and working professionals nationwide. The 7th edition was co-hosted by Kyushu University Medical Information Research Circle (QUMI) and iPS Portal Inc., with the theme of “Digital Transformation in Regenerative Medicine and Healthcare.”
Ozawa participated as a speaker at the kickoff event, creating an opportunity to discuss “real-world challenges and the potential for AI implementation” with participants.
Epistra will continue to collaborate with stakeholders in the life sciences, AI, and data science fields to “explore optimal approaches for research and implementation.”
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.